Search company, investor...
Densitas company logo

Densitas

densitas.health

Founded Year

2011

Stage

Seed | Alive

Total Raised

$360K

Revenue

$0000 

About Densitas

Densitas supports value-based care through advanced healthcare analytics powered by AI at the patient, clinic, and system levels. Its solutions provide on-demand insights for tailored risk-based management of patients and enable healthcare administrators to monitor clinical, quality, and operational performance indicators. The platform is designed to be PACS-centric by operating on the routinely archived standard DICOM images that radiologists review and supports point-of-care and retrospective processing of mammograms. Densitas was founded in 2011 and is based in Halifax, Canada.

Headquarters Location

1344 Summer Street #66

Halifax, Nova Scotia, B3H 0A8,

Canada

902-405-4610

Missing: Densitas's Product Demo & Case Studies

Promote your product offering to tech buyers.

Reach 1000s of buyers who use CB Insights to identify vendors, demo products, and make purchasing decisions.

Missing: Densitas's Product & Differentiators

Don’t let your products get skipped. Buyers use our vendor rankings to shortlist companies and drive requests for proposals (RFPs).

Expert Collections containing Densitas

Expert Collections are analyst-curated lists that highlight the companies you need to know in the most important technology spaces.

Densitas is included in 7 Expert Collections, including Women's Health & Wellness.

W

Women's Health & Wellness

1,482 items

Startups focused on providing products and services catering to women's health and wellbeing.

V

Value-Based Care & Population Health

1,077 items

The VBC & Population Health collection includes companies that enable and deliver care models that address the health needs for defining populations along the continuum of care, including in the community setting, through participation, engagement, and targeted interventions.

M

Medical Devices

12,088 items

Companies developing medical devices (per the IMDRF's definition of "medical device"). Includes software, lab-developed tests (LDTs), and combination products. *Columns updated as regularly as possible.

B

Biopharma Tech

5,241 items

Companies involved in the research, development, and commercialization of chemically- or biologically-derived therapeutic & theranostic drugs. Excludes vitamins/supplements, CROs/clinical trial services.

H

Health Monitoring & Diagnostics

2,849 items

Companies developing or offering products that aid in the assessment, screening, diagnosis, or monitoring of a person's state of health/wellness. Excludes companies focused solely on fitness/sports performance

D

Digital Health

13,118 items

Technologies, platforms, and systems that engage consumers for lifestyle, wellness, or health-related purposes; capture, store, or transmit health data; and/or support life science and clinical operations. (DiME, DTA, HealthXL, & NODE.Health)

Densitas Patents

Densitas has filed 1 patent.

The 3 most popular patent topics include:

  • Breast
  • Breast cancer
  • Feature detection (computer vision)
patents chart

Application Date

Grant Date

Title

Related Topics

Status

2/19/2018

11/13/2018

Breast cancer, Image processing, Medical imaging, Feature detection (computer vision), Breast

Grant

Application Date

2/19/2018

Grant Date

11/13/2018

Title

Related Topics

Breast cancer, Image processing, Medical imaging, Feature detection (computer vision), Breast

Status

Grant

Latest Densitas News

Densitas Connects to Nuance Precision Imaging Network to Empower Collaborative Care Teams and Improve Patient Outcomes with Workflow-Integrated AI

Nov 28, 2022

News provided by Share this article Share this article The secure nationwide AI-powered cloud platform streamlines care team communication and delivers patient-specific imaging insights within clinical workflows HALIFAX, NS, Nov. 28, 2022 /PRNewswire/ - Densitas® Inc., a global provider of AI solutions for digital mammography and breast screening, today announced that it has connected to the Nuance Precision Imaging Network™  (PIN), a secure nationwide cloud platform empowering collaborative care teams with streamlined communications and workflow-integrated AI insights from diagnostic imaging to improve healthcare outcomes and costs. Densitas® intelliMammo™ , comprising intelliMammo™ densityAI™, qualityAI™, and riskAI™, offers a FDA/ACR compliant solution for clinical and enterprise decision-making that includes breast density, breast cancer risk, and clinical image quality. IntelliMammo™ presents clinical care teams with on-demand actionable information and digitized workflows to systematically improve mammography quality, organizational and workflow efficiencies, and support early breast cancer detection and treatment. Leveraging the nationwide scale of the Nuance PowerScribe  and Nuance PowerShare diagnostic imaging solutions, the Nuance Precision Imaging Network connects radiologists, providers, health plans, self-insured employers, life science companies, and other imaging stakeholders to broaden access to precision diagnostics and therapeutics, increase healthcare efficiency, and lower costs. It enables secure and seamless sharing of AI insights from diagnostic imaging to enhance clinical decision-making, enhance care team collaboration, and facilitate the earlier detection and treatment of diseases for improved patient outcomes. "Our intelliMammo™ platform provides a solid foundation for population health management as patients navigate through breast cancer screening, diagnostic, treatment, and prevention pathways," said Mo Abdolell, CEO, of Densitas. "Through the Nuance Precision Imaging Network, intelliMammo™ becomes immediately accessible to over 10,000 healthcare facilities across the US. The addition of intelliMammo™ opens the door to Nuance customers to capture information from routine screening mammograms and seamlessly leverage patient-centered data and insights in their existing clinical and administrative workflows." "We're proud to support Densitas® with seamless workflow-integrated access through the Nuance Precision Imaging Network, providing powerful clinical decision support tools at the point-of-care as they advance their important work in breast cancer screening," said Roland Dias, Vice President, Precision Imaging Network, Nuance. About Densitas® Densitas® is a global leader in artificial intelligence solutions for breast cancer screening, focused on quality, safety, efficiency, and precision breast health. Densitas® designs intuitive solutions that boost the ability of hospitals and imaging centers that perform mammography to improve efficiencies, meet FDA/ACR compliance requirements, and support early breast cancer detection and treatment. For more information, visit www.densitashealth.com SOURCE Densitas Inc.

Densitas Web Traffic

Rank
Page Views per User (PVPU)
Page Views per Million (PVPM)
Reach per Million (RPM)
CBI Logo

Densitas Rank

Densitas Frequently Asked Questions (FAQ)

  • When was Densitas founded?

    Densitas was founded in 2011.

  • Where is Densitas's headquarters?

    Densitas's headquarters is located at 1344 Summer Street, Halifax.

  • What is Densitas's latest funding round?

    Densitas's latest funding round is Seed.

  • How much did Densitas raise?

    Densitas raised a total of $360K.

  • Who are the investors of Densitas?

    Investors of Densitas include Medteq, JLabs, Rogers Venture Partners and Innovacorp.

  • Who are Densitas's competitors?

    Competitors of Densitas include Ibex Medical Analytics, Butterfly Network, Koios Medical, Cleerly, Lunit, Aidoc Medical, Viz.ai, SenseTime, Overjet, Iterative Health and 24 more.

Compare Densitas to Competitors

S
Shukun Technology

Shukun Technology develops diagnostic systems by using machine learning and AI technology for hospitals to improve efficiency. The company focuses on cardiovascular diagnosis.

Ibex Medical Analytics Logo
Ibex Medical Analytics

Ibex Medical Analytics develops clinical decision support tools that help pathologists deliver metric-driven, objective and accurate diagnoses. It develops a diagnostic system that uses computer vision, machine learning, and electronic medical records to help confirm cancer diagnoses of tissue biopsies. The company was founded in 2016 and is based in Tel Aviv, Israel.

Caption Health Logo
Caption Health

Caption Health uses deep learning to help medical professionals in developing countries interpret ultrasounds so they can better treat heart disease. The company was founded in 2013 and is based in Brisbane, California.

RapidAI Logo
RapidAI

RapidAI is using AI to combat life-threatening vascular and neurovascular conditions. From home to hospital and ER to OR, RapidAI is leading the next evolution of clinical decision-making and patient workflow, bringing the end-to-end patient journey into focus.

R
RadNet

RadNet is a national provider of diagnostic imaging services in the United States. It offers a range of imaging services including digital and 3D mammography, X-ray, nuclear medicine, dual-energy X-ray absorptiometry (DEXA) for bone density measurement, and more. The company was founded in 1984 and is based in Los Angeles, California.

ScreenPoint Medical Logo
ScreenPoint Medical

ScreenPoint Medical, based in Nijmegen, has developed smart software for improving results of breast cancer screening. This software reads mammograms like a human reader and supports radiologists by identifying and interpreting potential problem areas on x-ray images. This reduces the chance of missing tumors and may be used to organize screening more efficiently.

Discover the right solution for your team

The CB Insights tech market intelligence platform analyzes millions of data points on vendors, products, partnerships, and patents to help your team find their next technology solution.

Request a demo

CBI websites generally use certain cookies to enable better interactions with our sites and services. Use of these cookies, which may be stored on your device, permits us to improve and customize your experience. You can read more about your cookie choices at our privacy policy here. By continuing to use this site you are consenting to these choices.